CytoSolv

About:

CytoSolv develops technology for the treatment of diabetic ulcers and other wounds.

Top Investors: National Science Foundation, Slater Technology Fund

Description:

CytoSolv Inc. engages in the development of a technology for the cure of diabetic ulcers. The company was founded in 2009 and is based in Tiverton, Rhode Island.

Total Funding Amount:

$650000

Headquarters Location:

Tiverton, Rhode Island, United States

Founded Date:

2009-01-01

Founders:

Moses Goddard

Number of Employees:

11-50

Last Funding Date:

2012-12-20

IPO Status:

Private

Industries: